Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The stock peaked at $7.68 once at 1:22 and again at 2:58 then declined to $7.45 @ the close. It rose to a high of $7.54 at 6:38 then plummeted after Glickman’s comments. The pros sold at the 1:22 pm peak. Day traders who did not anticipate the 1:22 took their opportunity at 2:58 pm. Even the semi-pros got out about $7.50.
Glickman did not help the stock by calling it speculative. Parents never call their baby ugly; so, here comes Glickman calling his baby ugly. Then, he said something that we all knew that it will be 2020 before we have results. Not too many people want to get in that early in a speculative stock. Also, there was no mention of being approached for a BO. Thus, the decline.
Some stocks make no sense to me...in fact, the stock market makes no sense to me. PRAN is a company with a $13.83 Book Value, it has 5 products in the pipeline. It's PBT2 is in Phase 2b trial as a treatment for Alzheimer’s and Huntington’s disease. One product to treat two different diseases. Yet the stock trades in the $2 range. Incredible!
you and me both. Looks like everyone has abandoned this stock. You can hear the crickets on this board.
Sounds like Shwab offers a good deal. How's the Shwab trading platform?
How do you keep your shares from being put on loan? Do you hold them in a cash account?
Some of you here are also in ARRY which had a positive news in their cancer research. The stock is moving after hours.
http://www.nasdaq.com/press-release/array-biopharma-announces-positive-topline-results-from-part-2-of-the-phase-3-columbus-study-of-20170509-01562
I thought the presentation was excellent. I am surprised by the plummeting price of the stock below $4. People must be hesitating in light of the anticipated earnings report on May 8. If the earnings are in line with expectations or better, the stock may climb above $4, and then the presentation the next day will send it higher. The question is when to buy.
That's old news dating back 3/30/17. So much has happened since. However, I pray for a $30 BO. That would really be sweet.
What news do you anticipate? Are you just hoping for news? At this point I can use some good news.
It should be a temp move to keep the shorts from finding shares to borrow for their short strategies. Remove the order at end of day. You are not to keep it overnight.
Postings on StockTwits are speculating there will be a short squeeze this afternoon in anticipation of a BO. I got to admit there were some large purchases this morning before the shorts hit hard. There is 10 times the usual volume today...that can’t be for nothing.
The bears are hoping to discourage folks into selling, and the longs say to put a limit order on your shares for $10 good for 45 days. If you do that the shares won’t be available for the shorts to borrow.
I’m a dude, 55 a week ago, been in the game since 2012. I have gained about 300% in a cash account lost 50% in a margin account (mostly due to ill-advised short positions). It just seemed rude not to say something as everyone was demasking. Nice diversity of age, how about gender?
I made some $$ in Ariad as a late-comer and followed the crowd from ARRY to AUPH. My concern with AUPH is the single drug pipeline and only in phase II. I am optimistically cautious because this could take more than two years. I am still in ARRY that has several drugs in the pipeline already in phase III with partners. This bunch dropped the stock after “Denner jumped ship.” So far, I’m losing $$ on both ARRY & AUPH.
Does anyone expect significant price appreciation in AUPH before 2019?
If only I had money, I would buy a boat load of this stock. The company has $9 cash per share. So, each share is worth $9 at a minimum. What do you all think?
If only I had money, I would buy a boat load of this stock. The company has $9 cash per share. So, each share is worth $9 at a minimum. What do you all think?
I followed a while also and rarely post anything because I have no expertise in this field.
I admire the passion on this board and the patience. It looks like you are willing to wait a couple of years for a successful Phase 3 or a BO. Keep the faith Ariad was worth the wait. I suspect so will AUPH.
So, do you plan to play this today? if so, how?
Wy did CRVS fall so hard beginning at 11 am? It all appears to be good news about the company, including the CMO buying shares holding a total of 166,300 March 17, 2017. Do you all expect it to rise tomorrow?
Luna, Grandma, and Vid have you practically given up on ARRY?
Why has MBLY closed down from the $63.53 takeover price? Am I misinformed about the $63.53 price? can anyone help explain this?
Will go any higher from the 5's level tomorrow?
Thanks for the reply, but not quite "Kill-or-Fill" which means All-or-None. We have to come up with our own phrase. See this link http://www.investopedia.com/terms/f/fok.asp
I was nervous when two different analysts downgraded the stock ahead of earnings. I asked, what were they seeing that I was not. I'm glad they were wrong. Let's ride ARRY into the 20's.
The shorts are in trouble. Those analysts who downgraded the stock did a good job in scaring the longs several days ago and got their respective firms' clients in the stock. That was the reverse of the pump-and-dump scheme. Who can come up with a good catchphrase for this? How's "Bump-then-buy"?
Someone is buying this stock big time. There have been two analyst reports downgrading this stock Leerink Swann on 1/30 and JP Morgan today and there is not the significant drop I would have expected to see.
Longs hand on to your shares, something is cooking. The downgrade may be one way to cheapen the stock for an entry point.
The next confirmed earnings announcement is expected on 10/25/2016.
I expect a good quarterly report and forecast in light of the trouble Samsung is having tapered by Google's entry in the market with its own phone. I hope the stock goes to 130.
I went on the SEC.gov site and pulled AOSL financials. It reflects the following:
Year Ended June 30, 2016, Net loss per share attributable to Alpha and Omega Semiconductor Limited of $-0.13 per share. I am confused by this because ON 8/10/16 the company's earnings report press release said it earned $+0.14 per share as of 6/30/16. Which is correct?
I would like to see a glossy annual report with the auditors' opinion. Can anyone help explain what's going on with this company?
Does anyone know when the audited financial statements are due?
AOSL is a very strong company. It is out performing all other companies in the semiconductor industry by 120%. Meaning it is out performing giants like INTC, AMAT, and comparable companies like ACLS, XCRA by 120%. In fact it is the only company in the industry hitting new highs. It hitt an all time high of $20.44 and the day is not over yet. It may surpass the B.RILEY forecast of $20.50.
Wow what a company!?
Are you saying that manipulators cannot influence the price of the stock because the company has complete control over the stock's trading price?
How is the company doing that? Do you know this for a fact or are you just guessing? I don't want to invest and lose everything to manipulators. It would be reassuring if the company did have complete control over its stock's price.
Can someone tell me why this stock even with a good earnings report and the buy recommendation is this stock worth a high of $19.77/shr or even $10. All of this gain based on one positive report. What if all stocks traded that way?
Jim Cramer appears to have gotten it right once again. There is already a chance to buy FB at $89 today. The stock is trading at $88.75 pre-market.